Intrasense Logo
FR0011179886
A1W6V5
ALINS.PA

Intrasense

Loading quotes...

Forecast

There is no analyst data available for this company.

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, Intrasense had revenue of €646k and net profit of -€6.37m
(EUR) June 2026
YoY
Revenue 646k -
Gross profit -4.9m -
Net profit -6.37m -
EBITDA -5.43m -

Fundamentals

Metric Value
Market capitalization
€10.76m
Number of shares
52.76m
52-week high/low
€0.47 - €0.18
Dividends No
Beta
0.54
P/E ratio
-0.76
PEG ratio
0.01
P/B ratio
-0.84
P/S ratio
5.36

Company profile

Intrasense SA designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. The company offers Myrian Imaging Layer, a multimodal visualization software platform suite for health industrials; Myrian Studio, a solution for the development of medical imaging applications for innovators, industrial clients, spin-offs, and research labs; and Myrian technologies to develop biomarkers and artificial intelligence solutions. It also provides Myrian Clinical Apps, a portfolio of clinical applications for advanced post-processing, which include Myrian XP-Breast; Myrian XP-Prostate; Myrian XP-Liver; Myrian XP-Mammo; Myrian XP-Lung; Myrian XP-Colon; Myrian XL-Onco, a lesion tracking solutions; Myrian XP-Vessel; Myrian XP-Cardiac; solution for pathology or organ; and various tools for the analysis of MRI, CT, conventional, radiology, and nuclear imaging exams. The company was incorporated in 2004 and is headquartered in Montpellier, France.

Name
Intrasense
CEO
Stephen Armand
Headquarters Montpellier, occ
France
Website
IPO
22/02/2012
Employees 76

Ticker symbols

Exchange Symbol
Euronext
ALINS.PA
Frankfurt
I8S.F
Paris
ALINS.PA
🍪

Parqet  uses cookies. Learn more